This intestinal-specific IL-17–microbiota–metabolism axis is of special interest because it differs from the traditional view of obesity as a proinflammatory state, where researchers found increased levels of IL-17A in the serum [266,267] and visceral adipose tissues [268]. The gene discussed is IL17A; the disease is obesity due to melanocortin 4 receptor deficiency.